| 药品名称 | (5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE |
|---|---|
| 分子靶点 | Dihydropyrimidine dehydrogenase [NADP(+)] |
| 药物类型 | Small Molecule |
| 研发阶段 | Experimental |
| 结构式 |
 |
| 分子量 | 446.5697 |
| 分子式 | C27H36F2O3 |
扩展信息
